Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension

OBJECTIVE: To test the hypothesis that levels of the endogenous inhibitor of NO production, asymmetric dimethylarginine (ADMA), would be greater in preterm infants with bronchopulmonary dysplasia (BPD) -associated pulmonary hypertension (PH) than in infants with BPD alone. STUDY DESIGN: A case contr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pediatr
Autores principales: Trittmann, Jennifer K., Peterson, Eric, Rogers, Lynette K., Chen, Bernadette, Backes, Carl H., Klebanoff, Mark A., Nelin, Leif D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308509/
https://ncbi.nlm.nih.gov/pubmed/25311706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2014.09.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares